Relative negative inotropic potencies of nine calcium channel blockers in cultured heart cells. 1988

V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
INSERM U 228, Faculté de Médecine Broussais-Hôtel Dieu, Paris, France.

The direct inhibitory effects on contractility and beating rate of the calcium channel blockers diltiazem, verapamil and dihydropyridine derivatives nicardipine, nifedipine, nitrendipine, PY 108-068, (+/- ) PN 200-110 and its 2 stereoisomers, were compared in cultured chick embryo ventricular cells. In spontaneously beating cells, the negative inotropic and chronotropic potencies of nicardipine, nifedipine, nitrendipine and PY 108-068 were not significantly different. The inhibitory effects of verapamil, nifedipine and nicardipine were studied in cells electrically driven at a frequency close to their spontaneous beating rate: verapamil, nifedipine and nicardipine had similar negative chronotropic potencies; when the rate of stimulation was increased 1.5 and 2-fold, a frequency-dependent inhibitory effect on contraction was shown for verapamil, but not for nifedipine and nicardipine. Therefore, in our model, where the effects of beating rate on the amplitude of contraction were taken into account, no significant difference in the direct negative inotropic potenties of nifedipine and nicardipine was shown.

UI MeSH Term Description Entries
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D046508 Culture Techniques Methods of maintaining or growing biological materials in controlled laboratory conditions. These include the cultures of CELLS; TISSUES; organs; or embryo in vitro. Both animal and plant tissues may be cultured by a variety of methods. Cultures may derive from normal or abnormal tissues, and consist of a single cell type or mixed cell types. Culture Technique,Technique, Culture,Techniques, Culture

Related Publications

V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
October 1987, The Journal of pharmacology and experimental therapeutics,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
April 1991, The Journal of pharmacology and experimental therapeutics,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
December 1988, Journal of cardiovascular pharmacology,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
October 1995, Biochemical pharmacology,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
January 1993, Pharmacotherapy,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
May 1985, British journal of pharmacology,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
November 1986, Naunyn-Schmiedeberg's archives of pharmacology,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
June 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
October 1993, Journal of the American College of Cardiology,
V Briand, and S Laurent, and J F Vaxelaire, and L Micheli, and M C Auclair, and H Schmitt
January 1998, Cardiology,
Copied contents to your clipboard!